Topline data were announced from a phase 3b trial evaluating the concomitant use of ixekizumab and tirzepatide in adults with active psoriatic arthritis and obesity.
Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the novel TOGETHER-PsA open-label Phase 3b ...
ProRx Pharma is moving to disrupt one of the fastest-growing corners of the medical wellness industry with the launch of an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback